Sumitomo Pharma Co., Ltd.
4506.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥119,120 | ¥108,002 | ¥105,649 | ¥112,434 |
| % Growth | 10.3% | 2.2% | -6% | – |
| Cost of Goods Sold | ¥45,589 | ¥44,112 | ¥39,671 | ¥41,439 |
| Gross Profit | ¥73,531 | ¥63,890 | ¥65,978 | ¥70,995 |
| % Margin | 61.7% | 59.2% | 62.5% | 63.1% |
| R&D Expenses | ¥9,349 | ¥8,175 | ¥13,126 | ¥10,467 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥40,904 | ¥35,657 | ¥49,565 | ¥41,044 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | -¥12,291 | -¥1,921 |
| Operating Expenses | ¥50,253 | ¥43,832 | ¥50,400 | ¥49,590 |
| Operating Income | ¥23,278 | ¥20,058 | ¥15,578 | ¥21,405 |
| % Margin | 19.5% | 18.6% | 14.7% | 19% |
| Other Income/Exp. Net | ¥57,592 | -¥8,126 | -¥21,993 | ¥35,027 |
| Pre-Tax Income | ¥80,870 | ¥11,932 | -¥6,415 | ¥56,432 |
| Tax Expense | -¥6,784 | ¥726 | -¥8,830 | ¥2,984 |
| Net Income | ¥87,654 | ¥11,206 | ¥2,415 | ¥53,448 |
| % Margin | 73.6% | 10.4% | 2.3% | 47.5% |
| EPS | 220.63 | 28.21 | 6.08 | 134.53 |
| % Growth | 682.1% | 364% | -95.5% | – |
| EPS Diluted | 220.63 | 28.21 | 6.08 | 134.53 |
| Weighted Avg Shares Out | 397 | 397 | 397 | 397 |
| Weighted Avg Shares Out Dil | 397 | 397 | 397 | 397 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥654 | ¥585 | ¥0 | ¥15,643 |
| Interest Expense | ¥0 | ¥9,053 | ¥7,451 | ¥0 |
| Depreciation & Amortization | ¥5,278 | ¥5,203 | ¥5,807 | ¥6,066 |
| EBITDA | ¥86,148 | ¥26,188 | ¥5,604 | ¥27,471 |
| % Margin | 72.3% | 24.2% | 5.3% | 24.4% |